Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists

Dave L. Dixon; Ila M. Harris; Raniah Aljadeed; Keri C. Anderson; Anna Aycock; Craig Beavers; Elizabeth J. Beckman; Diana Isaacs; Emily McCoy; Anna Sandler; Joseph J. Saseen; Shivali Singh; Jamie Wagner

doi:10.1002/jac5.1743

Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists

Dave L. Dixon, Ila M. Harris, Raniah Aljadeed, Keri C. Anderson, Anna Aycock, Craig Beavers, Elizabeth J. Beckman, Diana Isaacs, Emily McCoy, Anna Sandler, Joseph J. Saseen, Shivali Singh, Jamie Wagner

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

All health care professionals have a responsibility to integrate current evidence-based medicine into their clinical practice to ensure the best possible patient care. Clinical practice guidelines (CPGs) play a major role in helping clinicians identify when and how to implement evidence into routine clinical practice to improve patient outcomes. The primary intent of CPGs is to benefit patients by improving the quality of care; however, CPGs also improve efficiency and effectiveness within the health care system. The process used to develop CPGs is important to ensure the recommendations are trustworthy, based on the highest-quality evidence, and free of significant conflicts of interest. The National Academy of Medicine (NAM) published guidance on best practices for developing CPGs in 1990 and again in 2011. Additional guidance is provided by various reporting checklists for CPGs, such as the Appraisal of Guidelines for Research & Evaluation (AGREE) II and Reporting Items for Practice Guidelines in Healthcare (RIGHT) instruments. However, analyses of published CPGs show inconsistent application of these best practices. This paper discusses the benefits of CPGs, reviews the guideline development process, discusses limitations in this process and in applying CPGs to patient care, identifies opportunities for improvement, provides considerations for educating learners and other health care professionals about CPGs, and examines the role of pharmacists in CPG development, dissemination, and implementation.

Original language	English (US)
Pages (from-to)	73-84
Number of pages	12
Journal	JACCP Journal of the American College of Clinical Pharmacy
Volume	6
Issue number	1
DOIs	https://doi.org/10.1002/jac5.1743
State	Published - Jan 2023

Bibliographical note

Funding Information:
The authors thank Marcia Buck and Larisa Cavallari for their support and critical review of the manuscript.

Publisher Copyright:
© 2022 The Authors. JACCP: Journal of the American College of Clinical Pharmacy published by Wiley Periodicals LLC on behalf of Pharmacotherapy Publications, Inc.

Keywords

clinical pharmacists
clinical practice guidelines
evidence-based medicine

Publisher link

10.1002/jac5.1743

Find It

Find It at U of M Libraries

Cite this

Dixon, D. L., Harris, I. M., Aljadeed, R., Anderson, K. C., Aycock, A., Beavers, C., Beckman, E. J., Isaacs, D., McCoy, E., Sandler, A., Saseen, J. J., Singh, S., & Wagner, J. (2023). Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists. JACCP Journal of the American College of Clinical Pharmacy, 6(1), 73-84. https://doi.org/10.1002/jac5.1743

Dixon, DL, Harris, IM, Aljadeed, R, Anderson, KC, Aycock, A, Beavers, C, Beckman, EJ, Isaacs, D, McCoy, E, Sandler, A, Saseen, JJ, Singh, S & Wagner, J 2023, 'Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists', JACCP Journal of the American College of Clinical Pharmacy, vol. 6, no. 1, pp. 73-84. https://doi.org/10.1002/jac5.1743

@article{07ceed216b1549c39353ce954ecdfa08,

title = "Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists",

abstract = "All health care professionals have a responsibility to integrate current evidence-based medicine into their clinical practice to ensure the best possible patient care. Clinical practice guidelines (CPGs) play a major role in helping clinicians identify when and how to implement evidence into routine clinical practice to improve patient outcomes. The primary intent of CPGs is to benefit patients by improving the quality of care; however, CPGs also improve efficiency and effectiveness within the health care system. The process used to develop CPGs is important to ensure the recommendations are trustworthy, based on the highest-quality evidence, and free of significant conflicts of interest. The National Academy of Medicine (NAM) published guidance on best practices for developing CPGs in 1990 and again in 2011. Additional guidance is provided by various reporting checklists for CPGs, such as the Appraisal of Guidelines for Research & Evaluation (AGREE) II and Reporting Items for Practice Guidelines in Healthcare (RIGHT) instruments. However, analyses of published CPGs show inconsistent application of these best practices. This paper discusses the benefits of CPGs, reviews the guideline development process, discusses limitations in this process and in applying CPGs to patient care, identifies opportunities for improvement, provides considerations for educating learners and other health care professionals about CPGs, and examines the role of pharmacists in CPG development, dissemination, and implementation.",

keywords = "clinical pharmacists, clinical practice guidelines, evidence-based medicine",

author = "Dixon, {Dave L.} and Harris, {Ila M.} and Raniah Aljadeed and Anderson, {Keri C.} and Anna Aycock and Craig Beavers and Beckman, {Elizabeth J.} and Diana Isaacs and Emily McCoy and Anna Sandler and Saseen, {Joseph J.} and Shivali Singh and Jamie Wagner",

note = "Funding Information: The authors thank Marcia Buck and Larisa Cavallari for their support and critical review of the manuscript. Publisher Copyright: {\textcopyright} 2022 The Authors. JACCP: Journal of the American College of Clinical Pharmacy published by Wiley Periodicals LLC on behalf of Pharmacotherapy Publications, Inc.",

year = "2023",

month = jan,

doi = "10.1002/jac5.1743",

language = "English (US)",

volume = "6",

pages = "73--84",

journal = "JACCP Journal of the American College of Clinical Pharmacy",

issn = "2574-9870",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "1",

}

TY - JOUR

T1 - Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists

AU - Dixon, Dave L.

AU - Harris, Ila M.

AU - Aljadeed, Raniah

AU - Anderson, Keri C.

AU - Aycock, Anna

AU - Beavers, Craig

AU - Beckman, Elizabeth J.

AU - Isaacs, Diana

AU - McCoy, Emily

AU - Sandler, Anna

AU - Saseen, Joseph J.

AU - Singh, Shivali

AU - Wagner, Jamie

N1 - Funding Information: The authors thank Marcia Buck and Larisa Cavallari for their support and critical review of the manuscript. Publisher Copyright: © 2022 The Authors. JACCP: Journal of the American College of Clinical Pharmacy published by Wiley Periodicals LLC on behalf of Pharmacotherapy Publications, Inc.

PY - 2023/1

Y1 - 2023/1

N2 - All health care professionals have a responsibility to integrate current evidence-based medicine into their clinical practice to ensure the best possible patient care. Clinical practice guidelines (CPGs) play a major role in helping clinicians identify when and how to implement evidence into routine clinical practice to improve patient outcomes. The primary intent of CPGs is to benefit patients by improving the quality of care; however, CPGs also improve efficiency and effectiveness within the health care system. The process used to develop CPGs is important to ensure the recommendations are trustworthy, based on the highest-quality evidence, and free of significant conflicts of interest. The National Academy of Medicine (NAM) published guidance on best practices for developing CPGs in 1990 and again in 2011. Additional guidance is provided by various reporting checklists for CPGs, such as the Appraisal of Guidelines for Research & Evaluation (AGREE) II and Reporting Items for Practice Guidelines in Healthcare (RIGHT) instruments. However, analyses of published CPGs show inconsistent application of these best practices. This paper discusses the benefits of CPGs, reviews the guideline development process, discusses limitations in this process and in applying CPGs to patient care, identifies opportunities for improvement, provides considerations for educating learners and other health care professionals about CPGs, and examines the role of pharmacists in CPG development, dissemination, and implementation.

AB - All health care professionals have a responsibility to integrate current evidence-based medicine into their clinical practice to ensure the best possible patient care. Clinical practice guidelines (CPGs) play a major role in helping clinicians identify when and how to implement evidence into routine clinical practice to improve patient outcomes. The primary intent of CPGs is to benefit patients by improving the quality of care; however, CPGs also improve efficiency and effectiveness within the health care system. The process used to develop CPGs is important to ensure the recommendations are trustworthy, based on the highest-quality evidence, and free of significant conflicts of interest. The National Academy of Medicine (NAM) published guidance on best practices for developing CPGs in 1990 and again in 2011. Additional guidance is provided by various reporting checklists for CPGs, such as the Appraisal of Guidelines for Research & Evaluation (AGREE) II and Reporting Items for Practice Guidelines in Healthcare (RIGHT) instruments. However, analyses of published CPGs show inconsistent application of these best practices. This paper discusses the benefits of CPGs, reviews the guideline development process, discusses limitations in this process and in applying CPGs to patient care, identifies opportunities for improvement, provides considerations for educating learners and other health care professionals about CPGs, and examines the role of pharmacists in CPG development, dissemination, and implementation.

KW - clinical pharmacists

KW - clinical practice guidelines

KW - evidence-based medicine

UR - http://www.scopus.com/inward/record.url?scp=85144131005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144131005&partnerID=8YFLogxK

U2 - 10.1002/jac5.1743

DO - 10.1002/jac5.1743

M3 - Article

AN - SCOPUS:85144131005

SN - 2574-9870

VL - 6

SP - 73

EP - 84

JO - JACCP Journal of the American College of Clinical Pharmacy

JF - JACCP Journal of the American College of Clinical Pharmacy

IS - 1

ER -

Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this